Jamie Forlenza, PharmD

Janssen Scientific Affairs, LLC
Health Economics and Outcomes Research
800 Ridgeview Drive
Horsham, PA
USA 19044
MRittenh@its.jnj.com

3180.3 Resource use and costs before and after taxane chemotherapy (CT) in commercially-insured men with metastatic prostate cancer (PC)
4331.0 Source of care, treatment history, and resource use in white (W) and non-white (NW) men with prostate cancer (PC): Results from a US survey